首页> 外文期刊>Journal of tissue engineering and regenerative medicine >Osteoclasts and their precursors are present in the induced-membrane during bone reconstruction using the Masquelet technique
【24h】

Osteoclasts and their precursors are present in the induced-membrane during bone reconstruction using the Masquelet technique

机译:在使用MASQUET技术期间,在骨重建期间诱导膜中存在骨核糖体及其前体

获取原文
获取原文并翻译 | 示例
           

摘要

In 2000, Masquelet reported a long bone reconstruction technique using an induced membrane formed around a polymethylmethacrylate (PMMA) spacer placed in the defect with appropriate stabilization followed by secondary bone graft after PMMA removal. This reconstruction procedure allows rapid and safe bone reformation for septic, traumatic, neoplastic or congenital bone defects. A rat model of the Masquelet technique was developed to further characterize the biological activities of this induced membrane. Our model allows healing of a critical-sized femoral defect (8 mm) by means of this procedure over a period of 18 weeks. Comparison of induced membranes obtained 3, 4, 5 and 6 weeks after PMMA insertion indicated that this tissue changes over time. Several mineralization spots and bone cells were observed in contact with the PMMA, when assessed by Alizarin Red, Von Kossa, Alkaline phosphatase and Tartrate-resistant acid phosphatase staining of the membranes. CTR (calcitonin receptor)- and RANK (Receptor Activator of Nuclear factor Kappa B)-positive mononuclear cells were detected in the induced membrane, confirming the presence of osteoclasts in this tissue. These cells were observed in a thin, highly cellular layer in the induced membrane in contact with the PMMA. Together, these findings suggest that the membrane is able to promote osteointegration of autologous corticocancellous bone grafts during the Masquelet technique by creating local conditions that may be favourable to graft bone remodelling and osteointegration. Copyright (C) 2014 John Wiley & Sons, Ltd.
机译:2000年,MASQUELET报告了使用围绕聚甲基丙烯酸甲酯(PMMA)间隔物形成的诱导膜的长骨重建技术,该诱导膜放置在具有适当稳定的缺陷中,然后在PMMA去除后进行次级骨移植物。这种重建过程允许用于脓毒症,创伤,肿瘤或先天性骨缺损的快速安全的骨改性。开发了一种大鼠模型,用于进一步表征该诱导膜的生物活性。我们的模型允许通过该程序在18周内通过此程序愈合临界大小的股骨缺陷(8 mm)。在PMMA插入后3,4,5和6周获得的诱导膜的比较表明该组织随时间变化。当通过茜素红色,von kossa,碱性磷酸酶和抗膜的酒石酸耐酸性磷酸酶染色评估,观察到与PMMA接触的几种矿化斑和骨细胞。 Ctr(Calcitonin受体) - 并在诱导膜中检测到核因子Kappa B) - 阳性单核细胞的等级(核因子Kappa B),确认在该组织中存在骨细胞。在与PMMA接触的诱导膜中,在诱导膜中观察到这些细胞在诱导膜中观察到。这些研究结果表明,通过产生可能有利于移植骨重塑和骨折叠的局部条件,膜能够在Masquelet技术期间促进自体皮质毛细骨移植物的骨囊肿。版权所有(c)2014 John Wiley&Sons,Ltd。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号